Scott Joy, MD
Internal Medicine · Englewood, CONPI 1144304205
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.4%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Lilly USA, LLC at 40.6% of the total. 2025 is the largest year on record at $23,422, more than ten times the $50 reported in 2019. Among internal medicine clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 63 payments — averaging $433.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$11K
- Axsome Therapeutics, Inc.$9K
- Pfizer$3K
- Eli Lilly$3K
- Eko Health, Inc.$500
- Heartflow, Inc.$156
- plus $521 from 15 others
What the payments were for
- Consulting fees$9,80036%
- Speaking & faculty fees$13,47549%
- Travel & lodging$2,75610%
- Food & beverage$1,2725%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 14 | $11,096 |
| Axsome Therapeutics, Inc. | 11 | $9,143 |
| Pfizer | 10 | $3,036 |
| Eli Lilly | 2 | $2,850 |
| Eko Health, Inc. | 1 | $500 |
| Heartflow, Inc. | 1 | $156 |
| GSK | 7 | $126 |
| Novo Nordisk | 3 | $69 |
| Johnson & Johnson | 2 | $50 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $27 |
| Hologic Sales And Service, LLC | 1 | $26 |
| Bayer | 1 | $26 |
| AbbVie | 1 | $24 |
| Amneal Pharmaceuticals LLC | 1 | $24 |
| Abiomed | 1 | $23 |
| Amgen | 1 | $22 |
| Sonex Health, Inc. | 1 | $22 |
| Dexcom, Inc. | 1 | $21 |
| Medtronic | 1 | $18 |
| Exeltis, USA Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$27,302 in reported general payments places this provider in the 95th percentile of 1,430 internal medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 138 | $173,946 |
| EliquisApixaban | 52 | $88,860 |
| TrulicityDulaglutide | 64 | $77,242 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $30,834 |
| XareltoRivaroxaban | 18 | $26,939 |
| TradjentaLinagliptin | 20 | $23,717 |
| FarxigaDapagliflozin Propanediol | 13 | $19,063 |
| MounjaroTirzepatide | 13 | $17,520 |
| JanuviaSitagliptin Phosphate | 12 | $15,590 |
| Atrovent HfaIpratropium Bromide | 12 | $12,439 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $11,545 |
| Spiriva HandihalerTiotropium Bromide | 17 | $10,460 |
| Atorvastatin Calcium | 497 | $4,356 |
| Testosterone | 11 | $3,707 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 23 | $3,031 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $11,096 | $94,76277 claims |
| PfizerEliquis | $3,036 | $88,86052 claims |
| GSKTrelegy Ellipta, Arnuity Ellipta | $126 | $33,39837 claims |
| Johnson & JohnsonXarelto | $50 | $26,93918 claims |
| AbbVieSynthroid | $24 | $2,29729 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $24 | $2,221212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,430 internal medicine providers in Colorado.
Other internal medicine in Englewood
- Ashwini ReddyEnglewood$6K
- Gilad GordonBoulder$476K
- Kathryn PolovitzParker$403K
- Monica GrafalsAvon$401K
- Luke WebbColorado Springs$287K
- Samuel PiedadColorado Springs$154K
- Sophia AmbrusoLittleton$62K
- Kristine KuhnAurora$61K
- Kenneth OleszekDenver$60K
- Munni SelagamsettyColorado Springs$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.